This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Pre-clinical stage Solutions
Transition your research to clinical development seamlessly with our comprehensive pre-clinical development solutions
Depth and breadth of expertise
With deep expertise across regulatory, nonclinical, CMC, clinical research and market access, we deliver integrated solutions tailored to your product’s unique challenges, ensuring alignment with regulatory and market demands.
Proven track record across all HealthTech products
Whether you are developing small molecules or more complex biologics or medical devices, we are backed by a proven track record of guiding innovative therapies through preclinical milestones and into clinical success, we are your trusted partner in accelerating development and reducing risk.
FAQs
How can we choose concentrations to be used in in vitro DDI studies?
It depends on product metabolism, the intended route of administration, and the type of DDI studies (inhibition vs. induction).
Can you help us generate nonclinical study reports, as we are lacking resources?
With pleasure! This activity is part of our DNA, and the complementary expertise of the nonclinical team allows drafting for any type of product and indication.
Related Glossary
Pre-Clinical Data
Target Product Profile (TPP)
In Silico
Absorption, Distribution, Metabolism and Excretion (ADME)
Ethics Committee (EC)
Overdose
Standard Exchange of Nonclinical Data (SEND)
Questions? Get the answers from our expert team
No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.